百奥赛图-b(02315)涨超5%,截至发稿,涨5.52%,报17.98港元,成交额916.98万港元。消息面上,百奥赛图与南京正大天晴共同宣布,双方合作开发的NTB003(原代号BCG009)注射液已收到国家药品监督管理局核准签发的《药物临床试验批准通知书》,适应症为甲状腺眼病(Thyroid Eye Disease, TED)。据悉,NTB003注射液是百奥赛图与南京正大天晴合作开发的第二代...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.